Search - tctmd.com

Displaying 101 - 120 of 121

Sort: Relevancy | Date

Presentation TCT 2013

Implications of Anatomy Assessment and Device Labeling: Is Increasing Off-Label Use a Bad Thing?

Presenter: Alan Lumsden

October 30, 2013

Presentation TCT 2013

Current Review of AAA Endografts and Newly Approved Devices: Matching the Device to the Patient

Presenter: David Deaton

October 30, 2013

Presentation TCT 2013

New Devices on the Horizon: Modest Improvements or Game Changing?

Presenter: Clifford Buckley

October 30, 2013

Presentation TCT 2013

Evolution in AAA Endograft Devices, Technique, and Outcomes

Presenter: Gary Ansel

October 30, 2013

News Daily News

Ambulatory EVAR an Option for One-Third of AAA Patients

Yael L. Maxwell

August 30, 2013

News Daily News

Flow-Modulating Stent Takes Novel Approach to AAA Treatment

June 20, 2013

News Daily News

No Long-term Mortality Difference Between Endovascular vs. Open AAA Repair

Caitlin E. Cox

November 25, 2012

News Conference News TCT 2012

Endurant Stent Graft for AAA Safe, Effective at 2 Years

October 29, 2012

Presentation TCT 2012

Anatomic Assessment and On-Label vs. Off-Label Device Use: Are There Implications for Long-Term Outcomes?

Presenter: Constantino Pena

October 25, 2012

Presentation TCT 2012

Review of Current AAA Endografts and Future Devices to Address Unmet Needs

Presenter: Constantino Pena

October 25, 2012

Presentation TCT 2012

Aortoiliac Aneurysmal Disease: Optimal Repair Techniques Using Available Devices

Presenter: Jacques Busquet

October 25, 2012

News Daily News

Meta-analysis: Mortality Rates Eventually Converge for EVAR, Surgical AAA Repair

Jason Kahn

October 17, 2012

Presentation ACVS 2012

Overview of Percutaneous Treatment of Aortic Diseases (TEVAR/EVAR) – Indications, Devices and Procedure Tips & Tricks

Presenter: Sanjay Mehrotra

August 04, 2012

News Daily News

European Professional Societies Outline Current TEVAR Practices

Caitlin E. Cox

May 10, 2012

News Daily News

Early Mortality Benefit of EVAR vs. Open AAA Repair Holds up Long-term

L.A. McKeown

April 18, 2012

News Daily News

Early Survival Advantage of TEVAR Over Surgery Reversed Over Long Term

December 01, 2011

News Conference News

Experimental System Targets Drugs to AAA Wall via Stent Graft

November 15, 2011

News Industry News

VALOR II Study Highlights Strengths of Valiant® Thoracic Stent Graft from Medtronic

June 18, 2011

News Daily News

Patient Selection Key to Improved Late Outcomes Among TEVAR Recipients

Leah Lawrence

June 17, 2011

News Daily News

Study Raises Concerns About Noncompliance with EVAR Guidelines for AAA

Jason Kahn

April 14, 2011

Advertisement

Implications of Anatomy Assessment and Device Labeling: Is Increasing Off-Label Use a Bad Thing?

Current Review of AAA Endografts and Newly Approved Devices: Matching the Device to the Patient

New Devices on the Horizon: Modest Improvements or Game Changing?

Evolution in AAA Endograft Devices, Technique, and Outcomes

Ambulatory EVAR an Option for One-Third of AAA Patients

Flow-Modulating Stent Takes Novel Approach to AAA Treatment

No Long-term Mortality Difference Between Endovascular vs. Open AAA Repair

Endurant Stent Graft for AAA Safe, Effective at 2 Years

Anatomic Assessment and On-Label vs. Off-Label Device Use: Are There Implications for Long-Term Outcomes?

Review of Current AAA Endografts and Future Devices to Address Unmet Needs

Aortoiliac Aneurysmal Disease: Optimal Repair Techniques Using Available Devices

Meta-analysis: Mortality Rates Eventually Converge for EVAR, Surgical AAA Repair

Overview of Percutaneous Treatment of Aortic Diseases (TEVAR/EVAR) – Indications, Devices and Procedure Tips & Tricks

European Professional Societies Outline Current TEVAR Practices

Early Mortality Benefit of EVAR vs. Open AAA Repair Holds up Long-term

Early Survival Advantage of TEVAR Over Surgery Reversed Over Long Term

Experimental System Targets Drugs to AAA Wall via Stent Graft

VALOR II Study Highlights Strengths of Valiant® Thoracic Stent Graft from Medtronic

Patient Selection Key to Improved Late Outcomes Among TEVAR Recipients

Study Raises Concerns About Noncompliance with EVAR Guidelines for AAA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content